Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 11 NVO U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact
May 11 NVO Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
May 10 NVO One in eight U.S. adults admits to GLP-1 usage as public awareness climbs
May 10 NVO Novo Nordisk enters deal to develop obesity therapy
May 9 NVO Novo Nordisk, Flagship to develop next-generation obesity drugs
May 9 NVO 3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy
May 9 NVO Novo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss Blockbuster
May 9 NVO Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
May 9 IONS The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 9 SMLR Semler Scientific First Quarter 2024 Earnings: Misses Expectations
May 9 NVO Novo taps another Flagship startup in search for next obesity drugs
May 8 IONS Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
May 8 SMLR Semler Scientific: Great Product Can Still Thrive Post Medicare Advantage
May 8 NVO Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
May 8 SMLR Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2024 Earnings Call Transcript
May 8 IONS Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
May 8 NVO Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
May 8 DXCM Estimating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
May 8 BLTE Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags